Press Releases

CAMBRIDGE, Mass., Feb. 10, 2020 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it will feature 11 presentations, including 10 posters, and one oral presentation highlighting its ongoing studies and commitment to rare lysosomal storage disorders at the 16th annual WORLDSymposium™ 2020

HOLON, Israel, Feb. 10, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its fourth quarter and full year 2019 financial results on Thursday, February 20, 2

REHOVOT, Israel, Feb. 10, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its Board of Directors as Chairman, effective immediately. Dr. Pomerantz is currently the President, Chief Executive Officer

SUNNYVALE, Calif., Feb. 10, 2020 /PRNewswire/ -- Cepheid today announced that in response to the rapid outbreak of a new coronavirus strain, the Company is developing an automated molecular test for the qualitative detection of 2019-nCoV. The test will be designed for use on any of its 23,000 GeneXpert® Systems placed worldwide and is expected to del

CHICAGO, Feb. 10, 2020 /PRNewswire/ -- ChildServ plans to revolutionize and humanize the way children and young people who have suffered trauma are being supported to ensure they are given every opportunity to heal and succeed.

SACRAMENTO, Calif., Feb. 10, 2020 /PRNewswire/ -- Wellin5, an innovative online telehealth counseling platform, today announced its acquisition of

SHELTON, Conn., Feb. 10, 2020 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) today announced results for its first fiscal quarter ending December 31, 2019. 

VENICE, Calif., Feb. 10, 2020 /PRNewswire/ -- Venice Family Clinic launched its 50th Anniversary celebration today, kicking off a year of activities to recognize the nonprofit community health center's leadership in providing comprehensive and high-quality care to people in need, pioneering innovations that improve the lives of patients around the c

PLYMOUTH MEETING, Pa., Feb. 10, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its DNA medicine INO-3107 in a Phase 1/2 trial for treatment of Recurrent Respiratory Papillomatosis or RRP. RRP is a rare disease caused by the

BEER-SHEVA, Israel, Feb. 10, 2020 /PRNewswire/ -- BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev, introduces a novel method developed by researchers at Ben-Gurion University